AtomVie Global Radiopharma (AtomVie) is excited to share an inspiring patient story from Egypt. This video, created by the Oncidium foundation, highlights the profound impact of radiopharmaceuticals on Mr. Adel, who is battling prostate cancer. Following a single treatment with Prostate Specific Membrane Antigen (PSMA) targeting radionuclide therapy, Mr. Adel’s near elimination of painkiller use has sparked hope among other patients and showcases a remarkable improvement in his quality of life within a short period. A special thanks to the Oncidium foundation for sharing this powerful story. Your dedication to patient care is truly inspiring. At AtomVie, we pride ourselves on transforming patients' lives with high-quality radiopharmaceuticals. We ship these life-changing radiotherapeutics to over 25 countries worldwide on a daily basis with over 99% reliability. As the demand for radiopharmaceuticals continues to grow, we are expanding with a new state-of-the-art 72,300 sq ft facility that will offer at least 10x the capacity of what we currently do to better serve patients globally. We will be attending the 3rd TRP US Summit 2024 in San Diego from July 30th to August 1st 2024. We look forward to meeting you and discussing how we can continue to support patients together. Watch Mr. Adel's journey here: https://lnkd.in/eZPe4zHT #AtomVieGlobalRadiopharma #Radiotherapeutics #PatientCare #TRPSummit2024 #GlobalImpact #ProstateCancer #CommercialManufacturing
AtomVie Global Radiopharma Inc.
Pharmaceutical Manufacturing
Hamilton, Ontario 8,570 followers
Empowering Next Generation Radiotherapeutics
About us
AtomVie Global Radiopharma Inc. ("AtomVie"), incorporated in late 2021, is a global leading CDMO for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals and the most recent spinout from the Centre for Probe Development and Commercialization (CPDC). AtomVie offers the full range of scientific, technical, regulatory, quality, logistics and business expertise combined with a specialized infrastructure for the development of your radiopharmaceuticals from Phase 1 to the commercial marketplace. With a state-of-the art purpose-built facility that will be operational in 2024, AtomVie empowers the development of your radiotherapeutics. For more information about AtomVie, visit our website or contact: [email protected].
- Website
-
https://www.atomvie.com/
External link for AtomVie Global Radiopharma Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Hamilton, Ontario
- Type
- Privately Held
Locations
-
Primary
1280 Main St W
Hamilton, Ontario L8S 4K1, CA
Employees at AtomVie Global Radiopharma Inc.
Updates
-
We're #hiring a new Quality Assurance Associate in Hamilton, Ontario. Apply today or share this post with your network.
-
At AtomVie Global Radiopharma (AtomVie), we are committed to supporting our employees' growth and success. We are thrilled to see Betty Wiens, our Director, Quality Control & Analytical Development, leading the way at CAFACHEM 2024! Her role as a facilitator on the SOCIETY OF RADIOPHARMACEUTICAL SCIENCES' Industry Engagement Board, alongside Brett M. from Telix Pharmaceuticals Limited and Valery Radchenko from TRIUMF, underscores our belief in fostering innovation through collaboration. Together, we are dedicated to transforming patients' lives with high-quality radiopharmaceuticals. #AtomVieGlobalRadiopharma #Radiopharmaceuticals #CAFACHEM2024 #TransformingLives #Innovation
With my co-facilitators from the SRS’s Industry Engagement Board (IEB) at CAFACHEM 2024. From left to right: Betty Wiens (AtomVie Global Radiopharma), Brett Miller (Telix), Valery Radchenko (TRIUMF). Our objective is to build bridges between academia and industry and our first workshop was a great learning experience for all of us. See what the Society for Radiopharmaceutical Sciences has to offer at www.srsweb.org and we hope to see you at a future conference!
-
We're #hiring a new Director, Quality Assurance in Hamilton, Ontario. Apply today or share this post with your network.
-
The countdown to the 3rd Targeted RadioPharmaceuticals (TRP) US Summit 2024 is on! We're thrilled to connect with industry experts in San Diego from July 30th to August 1st 2024. AtomVie Global Radiopharma (AtomVie), represented by our Director, Business Development, Ghadeer Shubassi, will be there to share insights on how we collaborate with multiple partners in transforming patients' lives with high-quality radiopharmaceuticals across various diseases, including potential applications for glioblastoma. As we prepare to launch our state-of-the-art manufacturing facility, let's explore collaborative strategies to bridge workforce gaps and ensure seamless clinical and commercial supply of radiopharmaceuticals. Connect with us at this pivotal summit to forge partnerships driving innovation in radiopharmaceutical therapies, advancing treatments for devastating diseases, including glioblastoma! And while we are on this topic, today, we honor World Glioblastoma Day. AtomVie reaffirms our unwavering commitment to advancing treatments for glioblastoma. As a leading CDMO that works alongside partners to develop innovative therapies, we stand with the glioblastoma community - patients, caregivers, and healthcare professionals alike - in our relentless pursuit of new and impactful treatment options. #AtomVieGlobalRadiopharma #TRPSummit2024 #Radiopharmaceuticals #CommercialManufacturing #WorldGlioblastomaDay #Glioblastomaawareness #Innovation
-
We're #hiring a new Health, Safety & Environment Manager in Hamilton, Ontario. Apply today or share this post with your network.
-
We're #hiring a new QA - Data Reviewer, Associate in Hamilton, Ontario. Apply today or share this post with your network.
-
We're #hiring a new QA Manager- Batch Release in Hamilton, Ontario. Apply today or share this post with your network.
-
We're #hiring a new Senior Analytical Chemist in Hamilton, Ontario. Apply today or share this post with your network.
-
AtomVie Global Radiopharma (AtomVie) is proud to be an event partner at the 3rd Targeted RadioPharmaceuticals (TRP) Summit US 2024 in San Diego from July 30th to August 1st 2024. Ghadeer Shubassi, our Director, Business Development, will be present to meet with you and unveil the latest on our new state-of-the-art manufacturing facility, currently under construction in Hamilton, Ontario. With more than 10x the capacity of what we currently offer, our new purpose-built and scalable 72,3000 sq ft facility along with our world class expertise in GMP manufacturing, AtomVie is poised to meet the increasing demand for clinical and commercial supply as well as global distribution of radiopharmaceuticals. Join us as we dive into the latest advancements and challenges in the radiopharmaceutical field. We look forward to connecting with key industry leaders and exploring new opportunities for partnerships! #AtomVieGlobalRadiopharma #TRPSummit2024 #Radiopharmaceuticals #CommercialManufacturing #TargetedRadiopharmaceuticals #Partnerships #Collaboration